Literature DB >> 10555177

Human rapid acquisition with relaxation enhancement imaging at 8 T without specific absorption rate violation.

A Kangarlu1, A M Abduljalil, C Schwarzbauer, D G Norris, P M Robitaille.   

Abstract

A standard fast imaging sequence, rapid acquisition with relaxation enhancement (RARE), has been applied to human magnetic resonance at 8 T. RARE is known for its speed, good contrast and high RF power content. Highly T2 weighted images, the hallmark of RARE imaging, were acquired from the human brain. It is demonstrated that while T2 values may be reduced at 8 T, high quality RARE images could still be acquired at this field strength. Most importantly however, it is demonstrated that RARE images could be acquired without violating specific absorption rate (SAR) guidelines. Since it is well known that T2 weighted images are of significant value in clinical diagnosis, the implementation of RARE at this field strength will provide ultra high field MRI (UHFMRI) with a valuable imaging protocol at this field strength without exceeding SAR limitations.

Entities:  

Mesh:

Year:  1999        PMID: 10555177     DOI: 10.1007/bf02634596

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  25 in total

1.  Cognitive, cardiac, and physiological safety studies in ultra high field magnetic resonance imaging.

Authors:  A Kangarlu; R E Burgess; H Zhu; T Nakayama; R L Hamlin; A M Abduljalil; P M Robitaille
Journal:  Magn Reson Imaging       Date:  1999-12       Impact factor: 2.546

2.  Acquisition of human multislice MR images at 8 Tesla.

Authors:  A M Abduljalil; A Kangarlu; X Zhang; R E Burgess; P M Robitaille
Journal:  J Comput Assist Tomogr       Date:  1999 May-Jun       Impact factor: 1.826

3.  On the application of ultra-fast RARE experiments.

Authors:  D G Norris; P Börnert; T Reese; D Leibfritz
Journal:  Magn Reson Med       Date:  1992-09       Impact factor: 4.668

Review 4.  Ultrafast T2-weighted imaging of the abdomen and pelvis: use of single shot fast spin-echo imaging.

Authors:  Y Tang; Y Yamashita; M Takahashi
Journal:  J Magn Reson Imaging       Date:  1998 Mar-Apr       Impact factor: 4.813

5.  T2-weighted MR imaging of focal hepatic lesions: comparison of various RARE and fat-suppressed spin-echo sequences.

Authors:  R C Semelka; J P Shoenut; R M Kroeker
Journal:  J Magn Reson Imaging       Date:  1993 Mar-Apr       Impact factor: 4.813

6.  Diffusion-weighted MR microscopy with fast spin-echo.

Authors:  C F Beaulieu; X Zhou; G P Cofer; G A Johnson
Journal:  Magn Reson Med       Date:  1993-08       Impact factor: 4.668

7.  Breath-hold projection magnetic resonance-cholangio-pancreaticography (MRCP): a new method for the examination of the bile and pancreatic ducts.

Authors:  J Laubenberger; M Büchert; B Schneider; U Blum; J Hennig; M Langer
Journal:  Magn Reson Med       Date:  1995-01       Impact factor: 4.668

8.  Torque free asymmetric gradient coils for echo planar imaging.

Authors:  A M Abduljalil; A H Aletras; P M Robitaille
Journal:  Magn Reson Med       Date:  1994-04       Impact factor: 4.668

9.  Human magnetic resonance imaging at 8 T.

Authors:  P M Robitaille; A M Abduljalil; A Kangarlu; X Zhang; Y Yu; R Burgess; S Bair; P Noa; L Yang; H Zhu; B Palmer; Z Jiang; D M Chakeres; D Spigos
Journal:  NMR Biomed       Date:  1998-10       Impact factor: 4.044

10.  Why fat is bright in RARE and fast spin-echo imaging.

Authors:  R M Henkelman; P A Hardy; J E Bishop; C S Poon; D B Plewes
Journal:  J Magn Reson Imaging       Date:  1992 Sep-Oct       Impact factor: 4.813

View more
  2 in total

Review 1.  [Clinical high- and ultrahigh-field MR and its interaction with biological systems].

Authors:  A Kangarlu; K T Baudendistel; J T Heverhagen; M V Knopp
Journal:  Radiologe       Date:  2004-01       Impact factor: 0.635

2.  Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla.

Authors:  A Kangarlu; E C Bourekas; A Ray-Chaudhury; K W Rammohan
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.